Community Health Worker Based Intervention to Improve Palliative Care
Launched by JOHNS HOPKINS UNIVERSITY · Jun 2, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This research is being done to establish the effectiveness of a Community Health Worker based palliative care intervention among African American patients with advanced solid organ malignancies and their care givers.
The investigators' long-term goal is to reduce the research-to-practice gap in utilization of evidence-based palliative care (PC) in African Americans with advanced cancer. The objectives of this study are to establish the effectiveness of a CHW-based palliative care intervention and develop generalizable knowledge on how contextual factors influence implementation.
Gender
ALL
Eligibility criteria
- Patient Inclusion Criteria:
- • Self-identified African American patients with advanced (AJCC stage III or IV) solid organ malignancy
- • \>=18 years old
- • English speaking
- • Intact cognition and ability to provide informed consent
- Patient Exclusion Criteria:
- • Participants \< 18 years of age
- • Participants who are already receiving palliative care services
- Caregiver Inclusion Criteria:
- • Adult (\>=18 years old) caregivers providing informal (unpaid) care to an eligible African American cancer patient (related or unrelated)
- • English speaking
- • Intact cognition and ability to provide informed consent
- Caregiver Exclusion Criteria:
- • Participants \< 18 years of age
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Baltimore, Maryland, United States
Birmingham, Alabama, United States
Salisbury, Maryland, United States
Patients applied
Trial Officials
Fabian M Johnston, MD, MHS
Principal Investigator
Johns Hopkins School of Medicine
Aarti Mathur, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials